compound tirzepatide no membership Compounded NYC: Online Program for Weight Loss COMPOUNDED TIRZEPATIDE

For weight management, Zepbound is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity, as an adjunct to reduced-calorie diet and increased physical activity

We emphasize the need for a balanced diet, regular physical activity, and ongoing behavioral support to maximize the benefits of these medications and minimize the risk of weight regain

While some women may find success in losing weight on the medications and then becoming pregnant, both doctors and the drugs' manufacturers do not advise taking the medications while pregnant

Tirzepatide is approved as Mounjaro (diabetes, May 2022) and Zepbound (obesity, November 2023)

In case of accidental ingestion or exposure, contact a poison control center or healthcare provider immediately